MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Surface EMG signal features of Parkinson’s disease may support interpretation of home-based measurement data

    S. Rissanen, M. Koivu, P. Hartikainen, A. Sinokki, P. Karjalainen, E. Pekkonen (Kuopio, Finland)

  • Surround inhibition (SI) in the human motor system during real life motor tasks.

    P. Kassavetis, T. Camacho, M. Levine, M. Hallett (Bethesda, USA)

  • Survey-Based study of marijuana used in Parkinson’s Disease patients

    R. Healy, J. Paulson, A. Deb, K. Smith (Worcester, USA)

  • Synchronous or asynchronous exercises is beneficial compared to no exercise in Brazilian people with Parkinson’s disease during COVID-19 pandemic.

    E. Tardelli, E. Okamoto, F. Tarallo, K. Tanaka, F. Santinelli, L. Simieli, E. Costa, F. Barbieri (São Paulo, Brazil)

  • Synergistic effects of short pulse and directional deep brain stimulation of the thalamic ventral intermediate area for essential tremor

    U. Hidding, M. Schaper, W. Hamel, M. Pötter-Nerger, C. Moll, C. Choe (Hamburg, Germany)

  • Syntactic and Theory of Mind difficulties in Huntington’s disease

    A. Nuzzi (Bari, Italy)

  • Systematic review of cognitive subtypes derived from data driven approaches in Parkinson’s disease

    D. Pourzinal, J. Yang, R. Lawson, K. Mcmahon, G. Byrne, N. Dissanayaka (Herston, Australia)

  • Targeted plasmaproteome identifies a distinct biomarker panel in early and prodromal Parkinson’s disease

    M. Bartl, J. Hallqvist, M. Dakna, S. Schade, C. Trenkwalder, F. Sixel-Döring, B. Mollenhauer, K. Mills (Göttingen, Germany)

  • Technology use in Parkinson’s disease and parkinsonism: a multicenter survey in real-life Healthy East Lombardy Parkinson (HELP-)network

    A. Pilotto, S. Nocivelli, D. Alimenti, J. Melgari, M. Bianchi, V. de Giuli, A. Magherini, M. Rizzeti, F. Pisano, T. Di Monda, M. Gennuso, S. Gipponi, E. Cottini, A. Imarisio, S. Masciocchi, B. Bagni, E. Magni, M. Sessa, M. Turla, B. Ferraro, P. Trippa, A. Prelle, A. Ciccone, A. Padovani (Brescia, Italy)

  • Technology-based adaptation of a natural history study of Parkinson disease during the COVID-19 pandemic

    S. Jensen-Roberts, E. Waddell, T. Myers, M. Pawlik, J. Soto, A. Sarkar, M. Coffey, E. Stevenson, R. Wilson, E. Dorsey, K. Lizarraga, C. Tarolli, R. Schneider, J. Adams (Rochester, USA)

  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 132
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley